This proposal aims at training an MD/PhD bioinformatician in the statistical genetics of DNA sequence analysis, and in psychiatric genetics more generally, through a project that takes a novel approach to analyzing next-generation sequencing (NGS) data for detection of rare variants critical to bipolar disorder (BP) susceptibility. BP has a substantial genetic component, but the underlying genetic and neurobiological triggers of the illness remain elusive. While BP genome-wide association studies (GWAS) have focused on common variants and recently identified several SNPs associated with BP, there remains a much-discussed """"""""missing heritability"""""""" problem. This strongly suggests that rare variants might play a critical role in BP susceptibility. With the advent of next-generation sequencing, a relatively low-cost, high-throughput approach to scanning the genome for rare variants is now available. While sequencing technology has seen enormous leaps forward and can now provide us with a torrent of data, the methods for making sense of the data are still catching up. While disease-based sequencing can turn up thousands of rare variants in cases, there exists no robust method for determining which of them plays an etiologic role in the illness. The applicant will take advantage of a unique resource, a newly funded project to use NGS of 800 BP cases and 800 controls across the 1,500 synaptome genes (which encode proteins expressed in the brain synapses), to implement novel methods for analysis of rare susceptibility variants for BP. The applicant proposes to take advantage of a powerful recently developed statistical technique for dealing with rare events, exact logistic regression, and incorporate it into an algorithm for assessing associations between rare variants and disease. This project will be accomplished through the following specific aims: 1) Develop new bioinformatics tools for functional characterization and categorization of identified genetic variants, 2) Develop novel analytic methods to test associations of rare variants with disease, and 3) Test for association of rare variants in BP. This proposal will allow for the development of the applicant as an expert in bringing together bioinformatics and statistical genetics. Results from this study will provide new insights to the etiology and pathophysiology of BP, an important psychiatric illness in the population. In addition, it will provide a set of tools that will be widely applicable to the study of rare variants across complex common diseases.

Public Health Relevance

The goal of this K01 training award is for the Primary Investigator to pursue advanced training in statistical genetics and genetic epidemiology and employ these skills to develop novel analytic methods for analyzing rare variants in a high-throughput DNA sequencing project in bipolar disorder (BP). Results from this study will provide a set of tools that will be widely applicable to the study of rare variants across complex common diseases, and in addition, provide new insights to the etiology and pathophysiology of BP. It will also allow for the development of the applicant as an expert in bringing together bioinformatics and statistical genetics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01MH093809-04
Application #
8641719
Study Section
Genetics of Health and Disease Study Section (GHD)
Program Officer
Rosemond, Erica K
Project Start
2011-07-01
Project End
2016-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
4
Fiscal Year
2014
Total Cost
$177,961
Indirect Cost
$13,182
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Martin, P-M; Stanley, R E; Ross, A P et al. (2018) DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/?-catenin signaling. Mol Psychiatry 23:467-475
Monson, Eric T; Pirooznia, Mehdi; Parla, Jennifer et al. (2017) Assessment of Whole-Exome Sequence Data in Attempted Suicide within a Bipolar Disorder Cohort. Mol Neuropsychiatry 3:1-11
Goes, Fernando S; Pirooznia, Mehdi; Parla, Jennifer S et al. (2016) Exome Sequencing of Familial Bipolar Disorder. JAMA Psychiatry 73:590-7
Pirooznia, M; Wang, T; Avramopoulos, D et al. (2016) High-throughput sequencing of the synaptome in major depressive disorder. Mol Psychiatry 21:650-5
Roberts, Nicholas J; Norris, Alexis L; Petersen, Gloria M et al. (2016) Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov 6:166-75
Pirooznia, M; Seifuddin, F; Judy, J et al. (2014) Metamoodics: meta-analysis and bioinformatics resource for mood disorders. Mol Psychiatry 19:748-9
Pirooznia, Mehdi; Kramer, Melissa; Parla, Jennifer et al. (2014) Validation and assessment of variant calling pipelines for next-generation sequencing. Hum Genomics 8:14
Chen, Yun-Ching; Carter, Hannah; Parla, Jennifer et al. (2013) A hybrid likelihood model for sequence-based disease association studies. PLoS Genet 9:e1003224
Pirooznia, Mehdi; Seifuddin, Fayaz; Goes, Fernando S et al. (2013) SVAw - a web-based application tool for automated surrogate variable analysis of gene expression studies. Source Code Biol Med 8:8
Seifuddin, Fayaz; Pirooznia, Mehdi; Judy, Jennifer T et al. (2013) Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry 13:213

Showing the most recent 10 out of 16 publications